Minuti G,D Incecco A,Cappuzzo F . Targeted therapy for NSCLC with driver mutations .Ceritinib in advanced anaplastic lymphoma kinase(ALK)-rearranged(ALK +)nonsmall cell lung cancer(NSCLC):Results of the ASCEND-1 trial .8 .刘晓晴.晚期NSCLC维持治疗质疑与问题解析.中国肺癌杂志,201 ......